Discovery Innovation – Productive Partnering For Shared Success

October 15, 2010
Sales and Marketing Kinapse, White paper

Partnering is an integral feature within today’s pharmaceutical industry. While the conventional wisdom suggests that Phase II represents the optimum …

Nycomed COPD iPhone app

Digital Pharma: Pharma iPhone app update

October 15, 2010
Medical Communications Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone

The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …

Edelman acquires Dutch firm Hinfelaar

October 15, 2010
Medical Communications Edelman, Hinfelaar

Edelman has acquired leading Dutch PR agency Hinfelaar to strengthen its position as one of the largest agencies in the …

Swiss pharma company Roche

Roche revenue depressed by plummeting Tamiflu sales

October 15, 2010
Sales and Marketing 2010 financials, Q3, Roche

Roche suffered a 3% drop in group revenue in the third quarter as sales of its Tamiflu plummeted by 90 …

Contract research news in brief

October 15, 2010
Research and Development Clinipace, Covance, PPD, Quintiles, Synexus, cellectis

Our latest crop of contract research news includes updates from Clinipace, PPD, Cellectis bioresearch, Covance, Quintiles and Synexus. US contract …

Pharma-academia links under ‘greater scrutiny’

October 15, 2010
Medical Communications Recognition Academy, academia, industry relations, industry reputation

A company aiming to form a bridge between health providers and the pharma sector has warned that academics and clinicians …

Andy_Smaller

Orital appoints Andy Yeoman

October 15, 2010
Business Services, Medical Communications Orital, appointment, medical communications

Andy Yeoman has joined digital healthcare consultancy Orital as a managing consultant.He has 20 years experience of working with the …

Government drops generic substitution plans

October 15, 2010
Sales and Marketing NHS, generics, government

The coalition government has dropped plans to implement generic substitution in England. The Pharmaceutical Price Regulation Scheme (PPRS), a scheme …

PAN boosts account handling team

October 15, 2010
Medical Communications Pan, appointment, medical communications

UK advertising agency PAN has made two new appointments and three promotions.Andisheh Thomson joins as account manager and Natalie Enniks …

Celgene completes Abraxis takeover

October 15, 2010
Research and Development, Sales and Marketing Abraxane, Abraxis, Celgene, mergers and acquisitions, oncology

Celgene has completed its acquisition of Abraxis BioScience for cash and stock totalling $2.9 billion. The takeover gives the cancer …

Video exclusive: PM Society Digital Awards 2010

October 14, 2010
Medical Communications PM Society Digital Awards, awards, digi, pm society

Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in the field of digital communications …

Researchers unearth Pfizer’s buried data

October 14, 2010
Research and Development Ben Goldacre, Pfizer, publication, reboxetine, trial data

Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …

Phil Loder pic - Alpha-Plus 23Sep10

Philip Loder joins Alpha-Plus Medical Communications

October 14, 2010
Medical Communications Alpha-Plus, Alpha-Plus Medical Communications, Client Service Director, appointment, fishawack, medical communications

High Wycombe, UK-based Alpha-Plus Medical Communications has appointed Dr Phil Loder as client service director. He has 16 years of …

Pharma manufacturing news in brief

October 14, 2010
Manufacturing and Production Accucaps, Fresenius Kabi, ImmunoCellular Therapeutics, Laureate Pharma, SAFC Pharma

This week’s round-up of pharmaceutical manufacturing news includes a recall for Fresenius Kabi, facility updates from SAFC and Laureate Pharma …

NICE rejects GSK Tyverb appeal

October 14, 2010
Sales and Marketing GlaxoSmithKline, NICE, Tyverb

NICE’s independent appeal board has ruled the UK drug’s watchdog did not exceed its powers when issuing guidance on GlaxoSmithKline’s …

Merck Serono eyes ‘Nanobody’ potential in rheumatology

October 14, 2010
Research and Development Ablynx, Merck Serono

Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …

UK invests £50m in targeted research

October 13, 2010
Research and Development BIA, clinical research, genomics, personalised medicine, targeting

The government is to put more than £50 million of funding into a new initiative to produce more targeted research …

China driving global pharma growth

October 13, 2010
Sales and Marketing China, emerging markets, sales

The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …

Pfizer acquires King Pharmaceuticals for $3.6bn

October 13, 2010
Sales and Marketing King Pharmaceuticals, Pfizer, pain therapeutics

Pfizer is to purchase King Pharmaceuticals for $3.6 billion to significantly strengthen its pain portfolio and continue to diversify its …

The Gateway to Local Adoption Series

Latest content